Clinical Trial Update: CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)

View source ↗

Summary

This clinical trial update describes the NLG-PCNSL-01 study evaluating circulating tumor DNA for early response assessment in primary central nervous system lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: Nordic Lymphoma Group | Conditions: Primary Central Nervous System (CNS) Lymphoma | Status: RECRUITING